Original Source(s)
Related Content
Tirzepatide’s cardiovascular effects in clinical practice
Investigators compared cardiovascular outcomes with tirzepatide and a placebo proxy in patients with type 2 diabetes and established atherosclerotic cardiovascular disease.
August 28, 2026
-
4 min
Correlations between multiple obesity diagnostic criteria and fracture risk as well as cardiovascular diseases in patients with diabetes mellitus
by Zhenrun Zhan, Ke Zheng, Yalong Tu, Chao Lan, Lifeng Zheng
July 21, 2026
2025 BP Guideline Could Reduce Mortality
Modeling of nationally representative US data suggested broader implementation of the AHA/ACC 's 2025 recommendations could expand antihypertensive treatment eligibility and reduce long-term mortality among high-risk adults.
July 29, 2026
-
4 min